The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain

Neuroscience Letters

Volumn 221, Issue 2-3, 1997, Pages 157-160

  Herzberg, U ^a   Eliav, E ^b   Bennett, G J ^b   Kopin, Irwin J ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

cannabinoid agonist; neuropathic pain; R(+) WIN 55,212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; RIMONABANT;

ALLODYNIA; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; ENANTIOMER; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROPATHY; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SCIATIC NERVE;

ANALGESICS, NON-NARCOTIC; ANIMALS; CANNABINOIDS; HEAT; HYPERALGESIA; INJECTIONS, INTRAPERITONEAL; MALE; MORPHOLINES; NAPHTHALENES; PAIN; PERIPHERAL NERVOUS SYSTEM DISEASES; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 0342762087     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(96)13308-5     Document Type: Article

References (15)

1. Bennett, G.J. and Xie, Y.-K., A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man, Pain, 33 (1988) 87-107.
2. Carlton, S.M., Lekan, H.A., Kim, S.H. and Chung, J.M., Behavioral manifestations of an experimental model for peripheral neuropathy produced by spinal nerve ligation in the primate, Pain, 56 (1994) 155-166.
3. Clark, W.G., Changes in body temperature after administration of antipyretics, LSD, delta 9-THC and related agents II, Neurosci. Biobehav. Rev., 11 (1987) 35-96.
4. D'Ambra, T.E., Estep, K.G., Bell, M.R., Eissenestat, M.A., Josef, K.A., Ward, S.J., Haycock, D.A., Baizman, E.R., Casiano, F.M., Begun, S.C., Chippari, S.M., Crego, J.D., Kullnig, R.K. and Daley, G.T., Conformationally restrained analogues of pravadoline: nanomolar potent, enantioselective, (aminoalkyl) indole agonists of the cannabinoid receptor, J. Med. Chem., 35 (1992) 124-135.
5. Doyle, S.A., Burstein, S.H., Dewey, W.L. and Welch, S.P., Further studies on the antinociceptive effects of delta-6-THC-7-oic acid, Agents Actions, 31 (1990) 157-163.
6. Hargreaves, K., Dubner, R., Brown, F., Flores, C. and Joris, J., A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia, Pain, 32 (1988) 77-88.
7. Hohmann, A.G., Martin, W.J., Tsou, K. and Walker, J.M., Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2, Life Sci., 56 (1995) 2111-2118.
8. Mao, J., Price, D.D., Hayes, R.L., Lu, J., Mayer, D.J. and Frenk, H., Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy, Brain Res., 605 (1993) 164-168.
9. Nadler, V., Mechoulam, R. and Sokolovsky, M., The non-psychotropic cannabinoid (+)(3S,4S)-7-hydroxy-delta 6-tetrahydrocannabinol 1,1-dimethylheptyl (HU-211) attenuates N-methyl-D-aspartate receptor-mediated neurotoxicity in primary cultures of rat forebrain, Neurosci. Lett., 162 (1993) 43-45.
10. Rinaldi-Carmona, M., Barth, F., Heaulme, M., Alonso, R., Shire, D., Congy, C., Soubrie, P., Breliere, J.C. and Le Fur, G., Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist, Life Sci., 56 (1995) 1941-1947.
11. Tal, M. and Bennett, G.J., Dextrorphan relieves neuropathic heatevoked hyperalgesia in the rat, Neurosci. Lett., 151 (1993) 107-110.
12. Tal, M. and Bennett, G.J., Extra-territorial pain in rats with peripheral mononeuropathy: mechano-hyperalgesia and mechanoallodynia in the territory of the uninjured nerve, Pain, 57 (1994) 375-382.
13. Tal, M. and Bennett, G.J., Neuropathic pain sensations are differentially sensitive to dextrorphan, NeuroReport, 5 (1994) 1438-1440.
14. Welch, S.P., Thomas, C. and Patrick, G.S., Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine, J. Pharmacol. Exp. Ther., 272 (1995) 310-321.
15. Wirguin, I., Mechoulam, R., Breuer, A., Schezen, E., Weidenfeld, J. and Brenner, T., Suppression of experimental autoimmune encephalomyelitis by cannabinoids, Immunopharmacology, 28 (1994) 209-214.